Williams, Eric E <br/><br/>
A constitutively active ErbB4 mutant inhibits drug-resistant colony formation by the DU-145 and PC-3 human prostate tumor cell lines.  [electronic resource] 

 -  Cancer letters  Mar 2003 
 - 67-74 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>0304-3835 
<br/><br/><label>Standard No.: </label>10.1016/s0304-3835(02)00690-0  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Cell Division<br/>Drug Resistance, Neoplasm<br/>ErbB Receptors--genetics<br/>Fibroblasts<br/>Gene Expression Regulation, Neoplastic<br/>Humans<br/>Male<br/>Mice<br/>Mutation--genetics<br/>Phosphorylation<br/>Phosphotyrosine--metabolism<br/>Prostatic Neoplasms--genetics<br/>Receptor, ErbB-4<br/>Tumor Cells, Cultured